Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer
Identifieur interne : 000080 ( PascalFrancis/Checkpoint ); précédent : 000079; suivant : 000081Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer
Auteurs : JIE DENG [États-Unis] ; Sheila H. Ridner [États-Unis] ; Mary S. Dietrich [États-Unis] ; Nancy Wells [États-Unis] ; Kenneth A. Wallston [États-Unis] ; Robert J. Sinard [États-Unis] ; Anthony J. Cmelak [États-Unis] ; Barbara A. Murphy [États-Unis]Source :
- Journal of pain and symptom management [ 0885-3924 ] ; 2012.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
Context. Because surgery, radiation, and/or chemotherapy disrupt lymphatic structures, damage soft tissue leading to scar tissue formation and fibrosis, and further affect lymphatic function, patients with head and neck cancer may be at high risk for developing secondary lymphedema. Yet, no published data are available regarding the prevalence of secondary lymphedema after head and neck cancer treatment. Objectives. The aim of this study was to examine prevalence of secondary lymphedema in patients with head and neck cancer. Methods. The study included 81 patients with head and neck cancer who were three months or more post-treatment. External lymphedema was staged using Foldi's lymphedema scale. Internal lymphedema was identified through a flexible fiber-optic endoscopic or mirror examination. Patterson's scale was used to grade degrees of internal lymphedema. Results. Of the 81 patients, 75.3% (61 of 81) had some form of late-effect lymphedema. Of those, 9.8% (6 of 61) only had external, 39.4% (24 of 61) only had internal, and 50.8% (31 of 61) had both types. Conclusion. Lymphedema is a common late effect in patients with head and neck cancer, and it develops in multiple external and internal anatomical locations. During physical examination and endoscopic procedures, clinicians should assess patients with head and neck cancer for late-effect lymphedema. Referral for treatment should be considered when lymphedema is noted. Research is needed to examine risk factors of lymphedema in patients with head and neck cancer and its effects on patients' symptoms, function, and quality of life.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:12-0157719Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer</title><author><name sortKey="Jie Deng" sort="Jie Deng" uniqKey="Jie Deng" last="Jie Deng">JIE DENG</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Biostatistics, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Wells, Nancy" sort="Wells, Nancy" uniqKey="Wells N" first="Nancy" last="Wells">Nancy Wells</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Wallston, Kenneth A" sort="Wallston, Kenneth A" uniqKey="Wallston K" first="Kenneth A." last="Wallston">Kenneth A. Wallston</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Sinard, Robert J" sort="Sinard, Robert J" uniqKey="Sinard R" first="Robert J." last="Sinard">Robert J. Sinard</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Cmelak, Anthony J" sort="Cmelak, Anthony J" uniqKey="Cmelak A" first="Anthony J." last="Cmelak">Anthony J. Cmelak</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Murphy, Barbara A" sort="Murphy, Barbara A" uniqKey="Murphy B" first="Barbara A." last="Murphy">Barbara A. Murphy</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">12-0157719</idno><date when="2012">2012</date><idno type="stanalyst">PASCAL 12-0157719 INIST</idno><idno type="RBID">Pascal:12-0157719</idno><idno type="wicri:Area/PascalFrancis/Corpus">000101</idno><idno type="wicri:Area/PascalFrancis/Curation">000856</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000080</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000080</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer</title><author><name sortKey="Jie Deng" sort="Jie Deng" uniqKey="Jie Deng" last="Jie Deng">JIE DENG</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Biostatistics, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Wells, Nancy" sort="Wells, Nancy" uniqKey="Wells N" first="Nancy" last="Wells">Nancy Wells</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Wallston, Kenneth A" sort="Wallston, Kenneth A" uniqKey="Wallston K" first="Kenneth A." last="Wallston">Kenneth A. Wallston</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Sinard, Robert J" sort="Sinard, Robert J" uniqKey="Sinard R" first="Robert J." last="Sinard">Robert J. Sinard</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Cmelak, Anthony J" sort="Cmelak, Anthony J" uniqKey="Cmelak A" first="Anthony J." last="Cmelak">Anthony J. Cmelak</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Murphy, Barbara A" sort="Murphy, Barbara A" uniqKey="Murphy B" first="Barbara A." last="Murphy">Barbara A. Murphy</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Tennessee</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Journal of pain and symptom management</title><title level="j" type="abbreviated">J. pain symptom manage.</title><idno type="ISSN">0885-3924</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of pain and symptom management</title><title level="j" type="abbreviated">J. pain symptom manage.</title><idno type="ISSN">0885-3924</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Epidemiology</term><term>Head and neck cancer</term><term>Human</term><term>Late</term><term>Lymphedema</term><term>Prevalence</term><term>Secondary</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Prévalence</term><term>Epidémiologie</term><term>Secondaire</term><term>Lymphoedème</term><term>Homme</term><term>Cancer de la tête et du cou</term><term>Tardif</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Context. Because surgery, radiation, and/or chemotherapy disrupt lymphatic structures, damage soft tissue leading to scar tissue formation and fibrosis, and further affect lymphatic function, patients with head and neck cancer may be at high risk for developing secondary lymphedema. Yet, no published data are available regarding the prevalence of secondary lymphedema after head and neck cancer treatment. Objectives. The aim of this study was to examine prevalence of secondary lymphedema in patients with head and neck cancer. Methods. The study included 81 patients with head and neck cancer who were three months or more post-treatment. External lymphedema was staged using Foldi's lymphedema scale. Internal lymphedema was identified through a flexible fiber-optic endoscopic or mirror examination. Patterson's scale was used to grade degrees of internal lymphedema. Results. Of the 81 patients, 75.3% (61 of 81) had some form of late-effect lymphedema. Of those, 9.8% (6 of 61) only had external, 39.4% (24 of 61) only had internal, and 50.8% (31 of 61) had both types. Conclusion. Lymphedema is a common late effect in patients with head and neck cancer, and it develops in multiple external and internal anatomical locations. During physical examination and endoscopic procedures, clinicians should assess patients with head and neck cancer for late-effect lymphedema. Referral for treatment should be considered when lymphedema is noted. Research is needed to examine risk factors of lymphedema in patients with head and neck cancer and its effects on patients' symptoms, function, and quality of life.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3924</s0></fA01><fA03 i2="1"><s0>J. pain symptom manage.</s0></fA03><fA05><s2>43</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer</s1></fA08><fA11 i1="01" i2="1"><s1>JIE DENG</s1></fA11><fA11 i1="02" i2="1"><s1>RIDNER (Sheila H.)</s1></fA11><fA11 i1="03" i2="1"><s1>DIETRICH (Mary S.)</s1></fA11><fA11 i1="04" i2="1"><s1>WELLS (Nancy)</s1></fA11><fA11 i1="05" i2="1"><s1>WALLSTON (Kenneth A.)</s1></fA11><fA11 i1="06" i2="1"><s1>SINARD (Robert J.)</s1></fA11><fA11 i1="07" i2="1"><s1>CMELAK (Anthony J.)</s1></fA11><fA11 i1="08" i2="1"><s1>MURPHY (Barbara A.)</s1></fA11><fA14 i1="01"><s1>School of Nursing, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Biostatistics, School of Medicine, Vanderbilt University</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>3 aut.</sZ></fA14><fA14 i1="03"><s1>Vanderbilt-Ingram Cancer Center</s1><s2>Nashville, Tennessee</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></fA14><fA20><s1>244-252</s1></fA20><fA21><s1>2012</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>21986</s2><s5>354000509743860090</s5></fA43><fA44><s0>0000</s0><s1>© 2012 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>23 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>12-0157719</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Journal of pain and symptom management</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Context. Because surgery, radiation, and/or chemotherapy disrupt lymphatic structures, damage soft tissue leading to scar tissue formation and fibrosis, and further affect lymphatic function, patients with head and neck cancer may be at high risk for developing secondary lymphedema. Yet, no published data are available regarding the prevalence of secondary lymphedema after head and neck cancer treatment. Objectives. The aim of this study was to examine prevalence of secondary lymphedema in patients with head and neck cancer. Methods. The study included 81 patients with head and neck cancer who were three months or more post-treatment. External lymphedema was staged using Foldi's lymphedema scale. Internal lymphedema was identified through a flexible fiber-optic endoscopic or mirror examination. Patterson's scale was used to grade degrees of internal lymphedema. Results. Of the 81 patients, 75.3% (61 of 81) had some form of late-effect lymphedema. Of those, 9.8% (6 of 61) only had external, 39.4% (24 of 61) only had internal, and 50.8% (31 of 61) had both types. Conclusion. Lymphedema is a common late effect in patients with head and neck cancer, and it develops in multiple external and internal anatomical locations. During physical examination and endoscopic procedures, clinicians should assess patients with head and neck cancer for late-effect lymphedema. Referral for treatment should be considered when lymphedema is noted. Research is needed to examine risk factors of lymphedema in patients with head and neck cancer and its effects on patients' symptoms, function, and quality of life.</s0></fC01><fC02 i1="01" i2="X"><s0>002B02</s0></fC02><fC02 i1="02" i2="X"><s0>002B12B04</s0></fC02><fC02 i1="03" i2="X"><s0>002B10A01</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Prévalence</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Prevalence</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Prevalencia</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Epidémiologie</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Epidemiology</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Epidemiología</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Secondaire</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Secondary</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Secundario</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Lymphoedème</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Lymphedema</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Linfedema</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Human</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Cancer de la tête et du cou</s0><s2>NM</s2><s5>06</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Head and neck cancer</s0><s2>NM</s2><s5>06</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Cáncer de cabeza y cuello</s0><s2>NM</s2><s5>06</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Tardif</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Late</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Tardío</s0><s5>07</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Pathologie ORL</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>ENT disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>ORL patología</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Tumeur maligne</s0><s2>NM</s2><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Malignant tumor</s0><s2>NM</s2><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Tumor maligno</s0><s2>NM</s2><s5>40</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Cancer</s0><s2>NM</s2></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Cancer</s0><s2>NM</s2></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Cáncer</s0><s2>NM</s2></fC07><fN21><s1>122</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>États-Unis</li></country><region><li>Tennessee</li></region></list><tree><country name="États-Unis"><region name="Tennessee"><name sortKey="Jie Deng" sort="Jie Deng" uniqKey="Jie Deng" last="Jie Deng">JIE DENG</name></region><name sortKey="Cmelak, Anthony J" sort="Cmelak, Anthony J" uniqKey="Cmelak A" first="Anthony J." last="Cmelak">Anthony J. Cmelak</name><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name><name sortKey="Murphy, Barbara A" sort="Murphy, Barbara A" uniqKey="Murphy B" first="Barbara A." last="Murphy">Barbara A. Murphy</name><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name><name sortKey="Sinard, Robert J" sort="Sinard, Robert J" uniqKey="Sinard R" first="Robert J." last="Sinard">Robert J. Sinard</name><name sortKey="Wallston, Kenneth A" sort="Wallston, Kenneth A" uniqKey="Wallston K" first="Kenneth A." last="Wallston">Kenneth A. Wallston</name><name sortKey="Wells, Nancy" sort="Wells, Nancy" uniqKey="Wells N" first="Nancy" last="Wells">Nancy Wells</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000080 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000080 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:12-0157719
|texte= Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer
}}
| This area was generated with Dilib version V0.6.31. |  |